Dabigatran Etexilate Capsule
Generic Name |
Dabigatran Etexilate |
---|---|
Strength |
75 mg / 110 mg / 150 mg |
Form |
Capsule |
Packaging |
Strip of 10 capsules |
Therapeutic use |
Cardiovascular Agent |
Manufacturing Period |
30 to 45 Days |
Available Composition of
Name | Strength | Therapeutic use | View More |
---|---|---|---|
Dabigatran Etexilate Capsule | 110 mg, 150 mg, 75 mg | Cardiovascular Agent |
Product Description For Dabigatran Etexilate Capsule
products details and uses
Dabigatran Etexilate Exporter India, Manufacturer, Wholesaler & Distributor
Dabigatran Etexilate capsules are a type of novel oral anticoagulant (NOAC) prescribed to lower the risk of blood clot formation in various serious health conditions. They are commonly used to help prevent clots that can lead to deep vein thrombosis (DVT), pulmonary embolism (PE), strokes, or heart attacks. By interfering with the body’s clotting process, this medication supports healthy blood flow and reduces the likelihood of dangerous clot-related complications in the legs, lungs, brain, or heart.
Our Role in the Pharmaceutical Supply Chain
We provide comprehensive pharmaceutical services from formulation to delivery, including:
- Dabigatran Etexilate Injection Manufacturer of high-quality Dabigatran Etexilate formulations under GMP-certified facilities
- Dabigatran Etexilate Injection Exporter of Dabigatran Etexilate to regulated and semi-regulated markets worldwide
- Dabigatran Etexilate Injection Wholesaler supplying to pharmacies, hospitals, and medical institutions
- Dabigatran Etexilate Injection Distributor for both domestic and international partners with scalable logistics support
Global Distribution Network
With a strong logistics and compliance framework, we successfully export Cefotaxime to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey